Prevent Cancer Foundation to join Fight Colorectal Cancer at the White House to address colorectal cancer screening needs
PARA PUBLICACIÓN INMEDIATA
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Washington, DC – Earlier this year, President Biden reignited the Cancer Moonshot with renewed leadership and ambitious goals to ‘end cancer as we know it.’ To address colorectal cancer, the White House has been working with national advocacy organization Fight Colorectal Cancer (Fight CRC) and other advocacy and industry leaders in the colorectal cancer community. On July 25, 2022, Carolyn “Bo” Aldigé, founder of el Fundación Prevenir el Cáncer, and 18 others will join Fight CRC at the White House to discuss their shared response to the President’s call to action to improve and increase access to colorectal cancer screening, with a special emphasis on reaching the underserved and the 44 million people who need to be screened.
“The hope is that we can find and agree on a collective strategy and tangible steps we can take to get more people screened for colorectal cancer. We applaud the Administration and the White House for including a specific call to action on cancer screening and early detection within the Cancer Moonshot initiative,” said Bo Aldigé.
Although colorectal cancer is preventable with oportuno screening and highly treatable if caught early, one in three people are not up-to-date with colorectal cancer screening. This was exacerbated by the COVID-19 pandemic—a January 2022 survey conducted by the Prevent Cancer Foundation found that one-half of Americans who had a scheduled in-person medical appointment missed, postponed and/or cancelled one or more of these appointments over the past two years. Despite the availability of several safe and effective colorectal cancer screening options, colorectal cancer remains the number two cause of death for men and women combined, with communities of color experiencing even higher incidence and mortality rates.
“We commend the bold vision to fight cancer by President Biden and the Moonshot program,” said Anjee Davis, President of Fight CRC. “It is our hope as catalysts for the colorectal cancer community that with this meeting, we can address inequities within colorectal cancer screening and make progress toward our Path to a Cure. Prevention plays a huge role in ending colorectal cancer. The White House asked for a plan to get more people screened, and we are here to deliver—leading with the power of the patient voice.”
Participants who will be attending the White House Meeting:
Carolyn “Bo” Aldigé – Prevent Cancer Foundation, Founder
Alexey Aleshin, MD – Natera, General Manager, Early Cancer Detection
Andrew Barnell, MBA – Geneoscopy Inc., CEO
Danielle Carnival, PhD – White House Cancer Moonshot, Coordinator
Austin Chiang, MD, MPH – Medtronic, CMO
Kevin Conroy – Exact Sciences, CEO
Anjee Davis, MPPA – Fight Colorectal Cancer, President
AmirAli Talasaz, PhD – Guardant Health, Co-CEO
Greg Hamilton, MBA – Epigenomics, CEO
Lisa Lacasse – American Cancer Society Cancer Action Network (ACS CAN), President
David Lieberman, MD, AGAF – American Gastroenterological Association, Former President
Molly McDonnell – Fight Colorectal Cancer, Director of Advocacy
Arif Nathoo, MD, MPA – Komodo Health, Co-Founder & CEO
Angela Nicholas, MD – Fight Colorectal Cancer, Board Member
Mike Nolan, MBA – Freenome, CEO
AmirAli Talasaz, PhD – Guardant Health, Co-CEO
Catharine Young, MPA – Office of Science & Technology Policy (OSTP), Senior Director
The meeting will be closed; however, for photos, b-roll or official comments before or after the roundtable, please contact media@fightcrc.org o kyra.meister@preventcancer.org.
###
About Fight Colorectal Cancer
Fight Colorectal Cancer (Fight CRC) is a leading patient-empowerment and advocacy organization in the United States, providing balanced and objective information on colon and rectal cancer research, treatment, and policy. They are relentless champions of hope, focused on funding promising, high-impact research endeavors while equipping advocates to influence legislation and policy for the collective good. Learn more at FightCRC.org.
Acerca de la Fundación Prevent Cancer®
La Fundación para Prevenir el Cáncer® es la única organización sin fines de lucro de EE. UU. centrada únicamente en salvar vidas en todas las poblaciones mediante la prevención y la detección temprana del cáncer. A través de la investigación, la educación, la divulgación y la promoción, hemos ayudado a innumerables personas a evitar un diagnóstico de cáncer o a detectarlo lo suficientemente temprano como para recibir un tratamiento exitoso.
La Fundación está avanzando para afrontar el desafío de reducir las muertes por cáncer en 40% para 2035. Para lograrlo, nos comprometemos a invertir $20 millones en tecnologías innovadoras para detectar el cáncer tempranamente y avanzar en la detección de múltiples cánceres, $10 millones para ampliar la detección del cáncer y la vacunación. acceso a comunidades médicamente desatendidas, y $10 millones para educar al público sobre las opciones de detección y vacunación.
Para mayor información por favor visite www.preventcancer.org.